We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Faron Pharmaceuticals Ltd on Monday noted a positive read-out regarding the ongoing Bexmab trial on myelodysplastic s ...
Faron Pharmaceuticals Oy 20 May 2024 Faron Pharmaceuticals Ltd. ("Faron" or the "Company") Inside Information: Faron Reports Initial Positive Phase 2 Read-out in HMA-resistant MDS ...
Faron Pharmaceuticals Oy 17 May 2024 Faron Pharmaceuticals Oy ("Faron" or the "Company") Issuance of warrants Company Announcement, 17 May 2024 at 18:00 (EEST) / 16:00 (BST) / 11:00 AM (EDT...
Faron Pharmaceuticals Oy 16 May 2024 Faron Pharmaceuticals Oy ("Faron" or the "Company") Faron founders and bexmarilimab developers selected as finalists for the European Inventor...
Faron Pharmaceuticals Oy 13 May 2024 The following amendment has been made to the 'Board Change ' announcement released on 30 April 2024 at 1:00 PM (BST) under RNS No. 6380M. Juho Jalkanen...
The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately re ...
Faron Pharmaceuticals Oy 30 April 2024 Faron Pharmaceuticals Oy ("Faron" or the "Company") Inside Information: Update on financial status · Further cash preservation extends runway into...
Faron Pharmaceuticals Oy 30 April 2024 Faron Pharmaceuticals Ltd. ("Faron" or the "Company") Board Change Company announcement, April 30, 2024 at 15:00 (EEST) / 1:00 PM (BST) / 8:00...
Faron Pharmaceuticals Oy 16 April 2024 Faron Pharmaceuticals Oy ("Faron" or the "Company") Faron confirms plans for the coming months under new leadership - Initial data from ongoing...
Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing J ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 23 | 10.6976744186 | 215 | 284 | 215 | 42720 | 253.52477282 | DE |
4 | 118 | 98.3333333333 | 120 | 284 | 120 | 23912 | 215.15458267 | DE |
12 | 113 | 90.4 | 125 | 284 | 117.5 | 30013 | 163.97583937 | DE |
26 | -27 | -10.1886792453 | 265 | 360 | 117.5 | 22165 | 180.68384309 | DE |
52 | -59 | -19.8653198653 | 297 | 360 | 117.5 | 16206 | 213.74843991 | DE |
156 | -139.5 | -36.9536423841 | 377.5 | 495 | 117.5 | 15088 | 270.73320369 | DE |
260 | 152.5 | 178.362573099 | 85.5 | 560 | 80.5 | 51965 | 243.18727701 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions